“…Because US-guided CNB using a spring-activated biopsy needle has been reported safe and effective by Quinn et al, 23 several investigators have demonstrated the usefulness of CNB in diagnosing thyroid nodules with 90.3% (range, 78.5%-100%) sensitivity and 98.4% (range, 87%-100%) positive predictive value for thyroid malignancy. [18][19][20][24][25][26] Currently, the role of CNB has focused on the diagnosis of nodules with previously nondiagnostic results on FNA and, therefore, on preventing unnecessary diagnostic surgery. 19,24,25,27 For the diagnosis of a specific type of malignancy, however, CNB has also showed the possibility of superior diagnostic performance to that of FNA for thyroid lymphoma, anaplastic carcinoma, and metastasis in a small series of studies.…”